Chapter 005

PART II: PHARMACOLOGY OF SPECIFIC DRUG GROUPS

Introduction to Autonomic Nervous System Drugs

Peter W. Abel and Michael T. Piascik

GENERAL REFERENCES

  1. Burnstock G, Ralevic V: Purinergic signaling and blood vessels in health and disease, Pharmacol Rev 66:102–192, 2013. PUBMED Abstract
  2. Biasi MD: Nicotinic mechanisms in the autonomic control of organ systems, J Neurobiology 53:568–579, 2002. PUBMED Abstract
  3. Caulfield MP, Birdsall JM: International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors, Pharmacol Rev 50:279–290, 1998. PUBMED Abstract
  4. Eglen RM: Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function, Auto Autocoid Pharmacol 26:219–233, 2006. PUBMED Abstract
  5. Goldstein DS: Adrenaline and Noradrenaline, Encyclopedia of Life Sciences John Wiley & Sons, 2010. www.els.net.
  6. Hargreaves KM, Dionne RA, Mueller GP, et al.: Naloxone, fentanyl, and diazepam modify plasma β-endorphin levels during surgery, Clin Pharmacol Ther 40:165–171, 1986. PUBMED Abstract
  7. Kalamida D, Poulas K, Avramopoulou V: Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity, FEBS Journal 274:3799–3845, 2007. PUBMED Abstract
  8. Lukas R, Changeux J-P, le Novère N, et al.: International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits, Pharmacol Rev 51:379–401, 1999. PUBMED Abstract
  9. Piascik MT, Perez DM: α1-Adrenergic receptors: new insights and directions, J Pharmacol Exp Ther 298:403–410, 2001. PUBMED Abstract
  10. Westfall TC, Westfall DP: Neurotransmission: the autonomic and somatic motor nervous systems. In Brunton LL, Chabner B, Knollman B, editors: Goodman and Gilman’s the Pharmacological Basis of Therapeutics, ed 12, McGraw-Hill, 2011.